Raccoon eyes in systemic AL amyloidosis
Ganglioneuroblastoma infiltrating the bone marrow in an adult
Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets
Myeloid-derived suppressor cells – their role in haemato-oncological malignancies and other cancers and possible implications for therapy
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers
Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas
Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO ( RUNX1/RUNX1T1 ), during myeloid differentiation
OSU-DY7, a novel D -tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway
Dyskeratosis congenita and the DNA damage response
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction
The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases
Re-transplantation after bortezomib-based therapy
Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukaemia
RUNX1 mutations are rare in chronic phase polycythaemia vera
ADA-SCID with ‘WAZA-ARI’ mutations that synergistically abolished ADA protein stability